Delivery Order SPE2DB22D3501-SPE2DB25FVT02
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,204.70 firm fixed-price delivery order is for the supply of 4559301259 - Hydrocortisone Val 0.2% Ointment 45GM. No set-aside was used for this award. The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.27 firm fixed-price delivery order is for the supply of 453.6 grams of 2.5% hydrocortisone ointment. The contract has a period of performance through March 4, 2025 and was not designated as a set-aside procurement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract, valued at $11,358.44, is for the delivery of 15 gram tubes of 0.2% hydrocortisone ointment. The contract has an ultimate completion date of March 27, 2025 and was awarded on March 26, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,125.85 firm-fixed-price contract is for the delivery of 4556497960 - Hydrocortisone Valerate 0.2% Ointment, 45g tubes. The award has no set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical...
This federal contract award, valued at $1,237.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567875636 - HYDROCORTISONE 1% CREAM 28GM, and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,027.92, is for the delivery of 4567421431 HYDROCORTISONE 2.5% CREAM 30GM. It is a firm fixed-price delivery order contract with a completion date of March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,530.08 firm fixed-price delivery order is for the supply of 15-gram tubes of 0.2% hydrocortisone ointment. The award is not designated as a set-aside contract. The DLA IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award, valued at $1,013.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Hydrocortisone Valerate 0.2% Ointment, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 15, 2023. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,453.91 firm fixed-price delivery order is for the supply of 4558513680 - HYDROCORTISONE VAL 0.2% OINTMT 45GM. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) through June 2025. The contract has no set-aside designation,...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 15 grams of 0.2% hydrocortisone ointment, valued at $1,737.31. The award has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, particularly the...